Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

AFLIBERCEPT

FDA · BLA · 2026-04-02

AgencyFDA
Submission typeBLA
Action date2026-04-02
BrandEYLEA HD
SponsorREGENERON PHARMACEUTICALS
RouteINJECTION

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T02:35:06.502Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:AFLIBERCEPT:2026-04-02

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

AFLIBERCEPT — approval | AEaH